Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

RETINOL BINDING PROTEIN - ANVISA Registration 80464810626

Access comprehensive regulatory information for RETINOL BINDING PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810626 and manufactured by WUHAN LIFE ORIGIN BIOTECH JOINT STOCK CO., LTD. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including Nanosens Ltda, TRIMERO DIAGNOSTICS, S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80464810626
Registration Details
ANVISA Registration Number: 80464810626
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

RETINOL BINDING PROTEIN em família
Risk Class II

Registration Details

80464810626

25351402611201877

09377976000152

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Feb 11, 2019

VIGENTE

09/18/2025 19:00:01